CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Chugai Pharmaceutical Publishes Transcript of FY2026 Q3 Financial Results Conference

By Public Technologies
  • Chugai Pharmaceutical’s October 27, 2026, FY2026 third-quarter results conference featured CEO Osamu Okuda and CFO Iwaaki Taniguchi.
  • Nine-month revenue reached JPY 1.07 trillion; core operating profit totaled JPY 536.1 billion.
  • Management expects to exceed its full-year forecast, with Actemra sales projected to beat expectations by more than JPY 10 billion.
  • ERP-related shipment front-loading boosted domestic sales by the low JPY 30 billion range; the one-time benefit will reverse in the fourth quarter.
  • Hemlibra’s autoinjector launch is targeted for Japan and global markets in 2027, with no material increase in the cost ratio expected.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chugai Pharmaceutical Co. Ltd. published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk